Please try another search
For the three months ended 31 March 2022, Synergy Innovation Co Ltd revenues decreased 4% to W17.99B. Net income increased 31% to W3.17B. Revenues reflect BIO TECH segment decrease of 39% to W3.39B, medical business segment decrease of 4% to W10.35B, South Korea (Country) segment decrease of 3% to W10.46B. Net income reflects Health Functional Food segment income increase from W38.1M to W281.3M.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 19476.03 | 21246.11 | 19353.06 | |
Gross Profit | 5912.48 | 7846.12 | 8351.56 | |
Operating Income | 1825.69 | 2905.77 | 4736.56 | |
Net Income | 1241.37 | 1229.41 | -1407.16 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 285901.06 | 248329.6 | 257257.68 | 237283.22 |
Total Liabilities | 63313.77 | 28894.48 | 40465.96 | 65868.36 |
Total Equity | 222587.29 | 219435.12 | 216791.72 | 171414.86 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 1220.33 | 21643.2 | 8611.59 | |
Cash From Investing Activities | -7127.93 | -22563.2 | 4723.86 | |
Cash From Financing Activities | -11887.1 | 27260.13 | -369.1 | |
Net Change in Cash | -17613.67 | 39000.33 | 303.77 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review